Issue Date
10 Dec - 12 Dec'25
Investment/lot
₹14,904
Price Range
₹154 - ₹162
Lot Size
92
IPO Size
₹920 Cr
Start date
10/12/2025
End date
12/12/2025
Allotment of bids
15/12/2025
Refund Initiation
16/12/2025
Listing on exchange
17/12/2025
The IPO of Park Medi World comprises a fresh issue and an offer for sale. Fresh issue aggregates up to ₹770 crores while offer for sale aggregates up to ₹150 crores. The total offer size aggregates up to ₹920 crores. The price band is ₹154 to ₹162 per share, and it’s a 100% book-built offer.
Park Medi World IPO opens on December 10, 2025 and closes on December 12, 2025. The allotment of shares will take place on December 15, 2025. The credit of shares to the Demat account will take place on December 16, 2025. The initiation of refunds will take place on December 16, 2025. The listing of shares will take place on December 17, 2025.
The lot size of shares in the IPO is 92. The minimum number of lots in the IPO for retail investors is 1. The minimum investment amount required by a retail investor is ₹14,904 based on the upper price.
Park Medi World is the second largest private hospital chain in North India with an aggregate bed capacity of 3,000 beds, and the largest private hospital chain in terms of bed capacity in Haryana with 1,600 beds located in the state as of September 30, 2024. It operates a network of 13 NABH accredited multi-super specialty hospitals under the ‘Park’ brand, of which seven hospitals are also NABL accredited, with eight hospitals in Haryana, one hospital in New Delhi, two hospitals in Punjab and two hospitals in Rajasthan.
The company plans to utilise the IPO proceeds for:
| Detail | Information |
|---|---|
Upper Price Band | ₹162 |
Fresh Issue | Aggregates up to ₹770 crores |
Offer for Sale | Aggregates up to ₹150 crores |
EPS in ₹ in FY25 | 5.55 |
| Application | Lots | Shares | Amount in INR |
|---|---|---|---|
Retail (Min) | 1 | 92 | 14,904 |
Retail (Max) | 13 | 1196 | 1,93,752 |
S-HNI (Min) | 14 | 1288 | 2,08,656 |
S-HNI (Max) | 67 | 6164 | 9,98,568 |
B-HNI (Min) | 68 | 6256 | 10,13,472 |
| Investor Category | Shares Offered |
|---|---|
QIBs | Not more than 50% of the net offer |
Non-institutional Investors (NIIs) | Not less than 15% of the net offer |
Retail-individual Investors (RIIs) | Not less than 35% of the net offer |
The domestic healthcare industry comprises the following major segments: healthcare delivery (hospitals, clinics), pharmaceuticals, medical devices, diagnostic services, medical equipment, and other support services to the healthcare players. Out of these, healthcare delivery forms the major part, the industry grew from ₹3.9 trillion in Fiscal 2019 to ₹ 6.3 trillion in Fiscal 2024 growing at a CAGR of approximately 10%.
From Fiscal 2024 to Fiscal 2028, it is expected to grow at a CAGR of approximately 10-12% to reach ₹ 9.4-9.8 trillion in FY28P. This growth in the healthcare industry is driven by factors such as an aging population, increased incidence of lifestyle diseases, growing healthcare awareness, technology adoption and a growing affluent middle class.
Park Medi World is the second largest private hospital chain in North India with an aggregate bed capacity of 3,000 beds, and the largest private hospital chain in terms of bed capacity in Haryana with 1,600 beds located in the state as of September 30, 2024.
It operates a network of 13 NABH accredited multi-super specialty hospitals under the ‘Park’ brand, of which seven hospitals are also NABL accredited, with eight hospitals in Haryana, one hospital in New Delhi, two hospitals in Punjab and two hospitals in Rajasthan, each committed to providing high-quality and affordable medical services across a diverse range of specialties.
| Company Name | Total Income (in ₹ crores) | EPS in ₹ | NAV Per Share (in ₹) | Return on Net Worth (in %) |
|---|---|---|---|---|
Park Medi World | 1425.974 | 5.55 | 26.58 | 20.08 |
Apollo Hospitals Enterprise | 21994.300 | 100.56 | 570.37 | 17.63 |
Fortis Healthcare | 7849.700 | 10.26 | 118.06 | 8.69 |
Narayana Hrudalaya | 5575.000 | 38.90 | 177.37 | 21.80 |
Max Healthcare Institute | 7184.100 | 11.07 | 96.50 | 11.47 |
Krishna Institute of Medical Sciences | 3067.000 | 9.61 | 53.43 | 17.89 |
Global Health | 3771.400 | 17.92 | 125.64 | 14.27 |
Jupiter Lifeline Hospitals | 1290.200 | 29.47 | 206.85 | 14.27 |
Yatharth Hospital & Trauma Care Services | 896.700 | 14.72 | 166.62 | 8.15 |
Anchor Investor Bidding Date
Anchor portion of the IPO opens for bidding on December 9, 2025.
IPO Registrar and Book Running Lead Managers
Park Medi World offers over 30 super specialty and specialty services, including internal medicine, neurology, urology, gastroenterology, general surgery, orthopedics and oncology. As of September 30, 2024, it had a dedicated team of 891 doctors and 1,912 nurses across hospitals, delivering clinical and patient care.
The revenue from operations of Park Medi World grew from ₹1254.595 crores in FY 23 to ₹1393.570 crores in FY 25. Its bed capacity increased from 2250 in FY 23 to 3000 in FY 25. Over the years, it has undertaken a series of acquisitions acquiring seven hospitals across North India, including in Faridabad, Karnal, Ambala, Behror, Palam Vihar, Sonipat and Mohali.
It adopted a cluster-based approach to grow its network of hospitals leveraging the benefits of proximity between hospitals leading to operational efficiencies and enabling it to benefit from economies of scale.
Park Medi World is the second largest private hospital chain in North India. It operates a network of 13 NABH accredited multi-super specialty hospitals under the ‘Park’ brand, of which seven hospitals are also NABL accredited, with eight hospitals in Haryana, one hospital in New Delhi, two hospitals in Punjab and two hospitals in Rajasthan.
| Parameter | FY25 | FY24 | FY23 |
|---|---|---|---|
Total Income | 1425.974 | 1263.084 | 1272.177 |
Profit Before Tax | 286.675 | 218.163 | 315.028 |
Profit After Tax | 213.215 | 152.007 | 228.186 |
EBITDA | 372.173 | 310.301 | 390.341 |
EPS in ₹ | 5.55 | 3.95 | 5.94 |
| Parameter | FY25 | FY24 | FY23 |
|---|---|---|---|
Profit Before Tax | 286.675 | 218.163 | 315.028 |
Net Cash Generated from/ (used in) Operating Activities | 191.151 | 361.435 | 195.029 |
Net Cash Flow from Investing Activities | (91.167) | (254.552) | (179.631) |
Net Cash from / (used in) Financing Activities | (73.606) | (130.302) | 1.514 |
Cash & Cash Equivalents at the End of the Year | 103.004 | 76.626 | 100.046 |
This article is for informational purposes only and does not constitute financial advice. It is not produced by the desk of the Kotak Securities Research Team, nor is it a report published by the Kotak Securities Research Team. The information presented is compiled from several secondary sources available on the internet and may change over time. Investors should conduct their research and consult with financial professionals before making any investment decisions. Read the full disclaimer here.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing. Please read the SEBI-prescribed Combined Risk Disclosure Document before investing. Brokerage will not exceed SEBI’s prescribed limit.
Park Medi World IPO will be allotted on 2025-12-15.
₹920 Cr is the issue size of Park Medi World IPO.
The minimum lot size is 92 shares and the investment required is ₹14904.
The price band of Park Medi World IPO is ₹154 to ₹162.
You can read more about Park Medi World and its IPO from the company’s red herring prospectus (RHP) here.
The Park Medi World IPO comprises a fresh issue and an offer for sale aggregating up to ₹770 crores and ₹150 crores. The total issue size is ₹920 crores.
The IPO opens on December 10, 2025 and closes on December 12, 2025.
The lot size of shares in this IPO is 92.
Dr. Ajit Gupta is the Chairman of Park Medi World.
To get more information about the IPO of Park Medi World, click on the company’s red herring prospectus here.